Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.66B |
| 2 |
ORIG
Ocean Rig UDW Inc. Class A Common Shares
ORIG
|
+$1.55B |
| 3 |
RTX Corp
RTX
|
+$664M |
| 4 |
NXP Semiconductors
NXPI
|
+$606M |
| 5 |
Walt Disney
DIS
|
+$528M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$1.46B |
| 2 |
KKR & Co
KKR
|
+$602M |
| 3 |
Meta Platforms (Facebook)
META
|
+$594M |
| 4 |
Mastercard
MA
|
+$560M |
| 5 |
Visa
V
|
+$502M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 30.15% |
| 2 | Technology | 10.69% |
| 3 | Financials | 10.06% |
| 4 | Healthcare | 8.47% |
| 5 | Industrials | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
5426
DELISTED
Guaranty Bancshares
GNTY
| $118K | ﹤0.01% |
4,083
-1,813
| -31% | -$50.8K |
2017 Q2
1 quarter
|
|
|
ADRA
5427
DELISTED
Invesco BLDRS Asia 50 ADR Index Fund
ADRA
| $118K | ﹤0.01% |
3,630
| – | – |
2013 Q3
16 quarters
|
|
|
CIF
5428
DELISTED
MFS Intermediate High Income Fund
CIF
| $117K | ﹤0.01% |
39,990
-74,984
| -65% | -$216K |
2013 Q3
16 quarters
|
|
5429
EPR Properties 9.00% Series E Preferred Shares
EPR.PRE
$105M
| $117K | ﹤0.01% |
3,272
| – | – |
2015 Q4
7 quarters
|
|
5430
Greene County Bancorp
GCBC
$583M
| $117K | ﹤0.01% |
7,802
-196
| -2% | -$2.52K |
2014 Q1
14 quarters
|
|
5431
Ranger Energy Services
RNGR
$342M
| $117K | ﹤0.01% |
+7,961
| New | +$114K |
2017 Q3
0 quarters
|
|
|
FAUS
5432
DELISTED
First Trust Australia AlphaDEX Fund
FAUS
| $116K | ﹤0.01% |
3,672
-3,198
| -47% | -$104K |
2014 Q4
11 quarters
|
|
|
DMTX
5433
DELISTED
Dimension Therapeutics, Inc
DMTX
| $115K | ﹤0.01% |
19,072
-80
| -0.4% | -$207 |
2015 Q4
7 quarters
|
|
|
ARAV
5434
DELISTED
Aravive, Inc. Common Stock
ARAV
| $114K | ﹤0.01% |
7,766
+1,673
| +27% | +$169K |
2014 Q2
13 quarters
|
|
5435
BlackRock Virginia Muni Bond Trust
BHV
$35.7M
| $113K | ﹤0.01% |
6,277
+512
| +9% | +$9.37K |
2013 Q2
17 quarters
|
|
5436
DELISTED
Overseas Shipholding Group Inc.
OSG
| $113K | ﹤0.01% |
43,137
+5,122
| +13% | +$13K |
2015 Q4
7 quarters
|
|
|
IID
5437
DELISTED
VOYA INTERNATIONAL HIGH DIVIDEND EQUITY INCOME FUND
IID
| $113K | ﹤0.01% |
14,620
+3,120
| +27% | +$23.2K |
2013 Q4
15 quarters
|
|
|
INFI
5438
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $112K | ﹤0.01% |
84,370
-22,142
| -21% | -$27.5K |
2013 Q2
17 quarters
|
|
|
FWP
5439
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $112K | ﹤0.01% |
2,643
+774
| +41% | +$107K |
2014 Q4
11 quarters
|
|
5440
Global X Copper Miners ETF NEW
COPX
$6.94B
| $111K | ﹤0.01% |
4,472
+3,184
| +247% | +$78.1K |
2013 Q2
17 quarters
|
|
5441
Zevra Therapeutics
ZVRA
$610M
| $111K | ﹤0.01% |
1,884
-7
| -0.4% | -$373 |
2015 Q2
9 quarters
|
|
|
FCCY
5442
DELISTED
1st Constitution Bancorp
FCCY
| $111K | ﹤0.01% |
6,112
-1,010
| -14% | -$17.5K |
2013 Q4
15 quarters
|
|
|
ARLZ
5443
DELISTED
Aralez Pharmaceuticals Inc.
ARLZ
| $110K | ﹤0.01% |
47,787
-55,168
| -54% | -$73.8K |
2016 Q1
6 quarters
|
|
5444
iShares Treasury Floating Rate Bond ETF
TFLO
$7.07B
| $109K | ﹤0.01% |
2,172
-290
| -12% | -$14.6K |
2014 Q4
11 quarters
|
|
5445
abrdn Emerging Markets Equity Income Fund
AEF
$352M
| $108K | ﹤0.01% |
12,911
-5,869
| -31% | -$46.2K |
2013 Q2
17 quarters
|
|
5446
inTEST
INTT
$167M
| $108K | ﹤0.01% |
12,961
+4,443
| +52% | +$33.7K |
2017 Q1
2 quarters
|
|
5447
Smith Micro Software
SMSI
$12.9M
| $108K | ﹤0.01% |
+2,412
| New | +$111K |
2017 Q3
0 quarters
|
|
5448
DELISTED
UBS AG FI Enhanced Large Cap Growth ETN
FBGX
| $108K | ﹤0.01% |
552
| – | – |
2015 Q4
7 quarters
|
|
5449
iShares GSCI Commodity Dynamic Roll Strategy ETF
COMT
$1.41B
| $107K | ﹤0.01% |
3,071
-231
| -7% | -$7.79K |
2015 Q1
10 quarters
|
|
5450
ProShares Ultra Russell2000
UWM
$219M
| $107K | ﹤0.01% |
3,216
-1,264
| -28% | -$38.1K |
2013 Q2
17 quarters
|
|
Similar funds
Morgan Stanley's Q3 2017 Portfolio in Review
As of Q3 2017, Morgan Stanley held 6,889 positions worth $334B, up 0.86% from $331B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Morgan Stanley's Q3 2017 filing shows 195 new, 3,466 increased, 2,508 reduced and 247 closed positions. Its largest new stake was JBG SMITH: 4,306,383 shares worth $147M. The largest sale was Reynolds American Inc, an estimated $1.46B.
By sector, the portfolio is most concentrated in Miscellaneous at 30% of assets, down from 31% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q3 2017 buy was JBG SMITH: 4,306,383 shares worth $147M.
- Morgan Stanley added most to iShares MSCI Emerging Markets ETF in Q3 2017, an estimated $1.66B increase.
- Morgan Stanley's biggest Q3 2017 reduction was KKR & Co, cutting an estimated $602M.
- Morgan Stanley fully exited Reynolds American Inc in Q3 2017, selling an estimated $1.46B.
- Morgan Stanley's ten largest holdings make up 12% of its $334B portfolio in Q3 2017.
- Morgan Stanley opened 195 new positions and closed 247 in Q3 2017.
- Morgan Stanley's portfolio value rose 0.86% quarter-over-quarter to $334B.
Based on Morgan Stanley's 13F filing for Q3 2017, filed 14 Nov 2017.